Phosphorylation of Ser-446 determines stability of MKP-7

被引:55
作者
Katagiri, C
Masuda, K
Urano, T
Yamashita, K
Araki, Y
Kikuchi, K
Shima, H
机构
[1] Hokkaido Univ, Div Biochem Oncol & Immunol, Inst Med Genet, Kita Ku, Sapporo, Hokkaido 0600815, Japan
[2] Nagoya Univ, Grad Sch Med, Dept Biochem 2, Showa Ku, Nagoya, Aichi 4660065, Japan
[3] Kanazawa Univ, Div Life Sci, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan
[4] Hokkaido Univ, Grad Sch Environm Earth Sci, Div Biosci, Sapporo, Hokkaido 0600810, Japan
关键词
D O I
10.1074/jbc.M500200200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
MAPK cascades can be negatively regulated by members of the MAPK phosphatase (MKP) family. However, how MKP activity is regulated is not well characterized. MKP-7, a JNK-specific phosphatase, possesses a unique COOH-terminal stretch (CTS) in addition to domains conserved among MKP family members. The CTS contains several motifs such as a nuclear localization signal, a nuclear export signal, PEST sequences, and a serine residue (Ser-446) that can be phosphorylated by activated ERK, suggesting an important regulatory role(s). S-35-pulse labeling experiments indicate that the half-life of MKP-7 is 1.5 h, a period significantly elongated by deleting the CTS. We also show that overexpressed MKP-7 is polyubiquitinated when co-expressed with ubiquitin and that proteasome inhibitors markedly inhibit MKP-7 degradation. We also determined that MKP-7 phosphorylated at Ser-446 has a longer half-life than unphosphorylated form of the wild type protein, as does a phospho-mimic mutant of MKP-7. These results indicate that activation of the ERK pathway strongly blocks JNK activation through stabilization of MKP-7 mediated by phosphorylation.
引用
收藏
页码:14716 / 14722
页数:7
相关论文
共 36 条
[1]  
Alonso A, 2004, TOP CURR GENET, V5, P333
[2]   Tyrosine phosphorylation of VHR phosphatase by ZAP-70 [J].
Alonso, A ;
Rahmouni, S ;
Williams, S ;
van Stipdonk, M ;
Jaroszewski, L ;
Godzik, A ;
Abraham, RT ;
Schoenberger, SP ;
Mustelin, T .
NATURE IMMUNOLOGY, 2003, 4 (01) :44-48
[3]   Constitutive activation of c-Jun N-terminal kinase by a mutant epidermal growth factor receptor [J].
Antonyak, MA ;
Moscatello, DK ;
Wong, AJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (05) :2817-2822
[4]   The JUN kinase stress-activated protein kinase pathway is required for epidermal growth factor stimulation of growth of human A549 lung carcinoma cells [J].
Bost, F ;
McKay, R ;
Dean, N ;
Mercola, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (52) :33422-33429
[5]   Two splice variants of protein kinase Bγ have different regulatory capacity depending on the presence or absence of the regulatory phosphorylation site serine 472 in the carboxyl-terminal hydrophobic domain [J].
Brodbeck, D ;
Hill, MM ;
Hemmings, BA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (31) :29550-29558
[6]   Reduced MAP kinase phosphatase-1 degradation after p42/p44MAPK-dependent phosphorylation [J].
Brondello, JM ;
Pouysségur, J ;
McKenzie, FR .
SCIENCE, 1999, 286 (5449) :2514-2517
[7]   Dual specificity phosphatases: a gene family for control of MAP kinase function [J].
Camps, M ;
Nichols, A ;
Arkinstall, S .
FASEB JOURNAL, 2000, 14 (01) :6-16
[8]   Mammalian MAP kinase signalling cascades [J].
Chang, LF ;
Karin, M .
NATURE, 2001, 410 (6824) :37-40
[9]   The ubiquitin-proteasome pathway: on protein death and cell life [J].
Ciechanover, A .
EMBO JOURNAL, 1998, 17 (24) :7151-7160
[10]   Structure and regulation of MAPK phosphatases [J].
Farooq, A ;
Zhou, MM .
CELLULAR SIGNALLING, 2004, 16 (07) :769-779